Alvotech (NASDAQ:ALVOW) Sees Significant Decrease in Short Interest

Alvotech (NASDAQ:ALVOW) saw a significant decline in short interest during the month of March. As of March 13th, there was short interest totaling 932 shares, a decline of 35.5% from the February 26th total of 1,444 shares. Based on an average daily trading volume, of 1,248 shares, the short-interest ratio is presently 0.7 days.

Alvotech Price Performance

Shares of NASDAQ ALVOW opened at $0.20 on Friday. The business’s 50-day simple moving average is $0.37 and its 200-day simple moving average is $0.79. Alvotech has a 52 week low of $0.15 and a 52 week high of $3.00.

About Alvotech

Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.

Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.